Observation of therapeutic effect of mizolastine combined with compound glycyrrhizin in chronic idiopathic urticaria

Journal of Clinical Dermatology

Volumn 41, Issue 11, 2012, Pages 695-698

  Zhang, Yan ^a   Shang, Ting ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Compound glycyrrhizin; Loratadine; Mizolastine; Urticaria, chronic

Indexed keywords

GLYCYRRHIZIC ACID; LORATADINE; MIZOLASTINE;

ARTICLE; CHRONIC IDIOPATHIC URTICARIA; CHRONIC URTICARIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 84872709890     PISSN: 10004963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Rosenzweig P, Caplain H, Chaufour S, et al. Comparative wheal and flare study of mizolastine vs terfenadine.cetifizine, lomtadine and placebo in healthy volunteers[J]. Br J Clin Pharmacol, 1995, 40(5): 459-465.
2. Wedi B, Novacovic V, Koemcer M, et al. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression -inhibitor efleets of anti -inflammatory drugs[J]. J Allergy Clin Immunol, 2000, 105(3): 552-560. (Pubitemid 30169915)
3. Carayol N, Crampette L, Mainprice B. et al. Inhihition of mediator and cytokine release from dispersed nasal polyp cells by mizolastine[J]. Allergy, 2002, 57: 1067-1070. (Pubitemid 35238646)
4. Binfeng Lu, Christoph E, Zlatko D, et al. Targeted disruption of the interfero-receptor 2 gene results in severe immune defects in mice [J]. Proc Notl Acad Sci USA, 1998, 95(14): 8233-8238.